Danilkovitch Alla

Avg. Two Year Performance

No purchase track record

65% Avg. Sale Return

29% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	(2%)	19%	64%	70%	65%
Sale Success Rate	0 of 1	1 of 1	1 of 1	1 of 1	1 of 1

Osiris Therapeutics, Inc.

Drugs » Biotechnology

Chief Scientific Officer:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--